Prenetics Global Stock (NASDAQ:PRE)
Previous Close
$4.75
52W Range
$2.85 - $7.84
50D Avg
$4.53
200D Avg
$5.02
Market Cap
$54.98M
Avg Vol (3M)
$19.07K
Beta
-0.21
Div Yield
-
PRE Company Profile
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE Performance
Peer Comparison
Ticker | Company |
---|---|
GTH | Genetron Holdings Limited |
XGN | Exagen Inc. |
LMDX | LumiraDx Limited |
SERA | Sera Prognostics, Inc. |
BNR | Burning Rock Biotech Limited |
QGEN | Qiagen N.V. |
CSTL | Castle Biosciences, Inc. |
ACRS | Aclaris Therapeutics, Inc. |
NOTV | Inotiv, Inc. |
DRIO | DarioHealth Corp. |
NEOG | Neogen Corporation |
OLK | Olink Holding AB (publ) |
BDSX | Biodesix, Inc. |
FONR | FONAR Corporation |
MDXH | MDxHealth SA |